Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Rix Brooks

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Toxicology and Applied Pharmacology|January 18, 2011
Methyl Vitamin B12 but not methylfolate rescues a motor neuron-like cell line from homocysteine-mediated cell deathRichelle A Hemendinger, Edward J Armstrong, Benjamin Rix Brooks
Trends in Molecular Medicine|April 1, 2009
Whole-genome association studies of sporadic amyotrophic lateral sclerosis: are retroelements involved?Jean-Luc Mougeot, Stephanie Richardson-Milazi, Benjamin Rix Brooks
Muscle & Nerve|February 7, 2026
Generalizability of Edaravone EfficacyBenjamin Rix Brooks, David L Ennist, Danielle Beaulieu, et al.
Toxicology and Applied Pharmacology|November 24, 2011
Neurotoxic injury pathways in differentiated mouse motor neuron-neuroblastoma hybrid (NSC-34D) cells in vitro--limited effect of riluzole on thapsigargin, but not staurosporine, hydrogen peroxide and homocysteine neurotoxicityRichelle A Hemendinger, Edward J Armstrong, Nick Radio, et al.
Journal of the Neurological Sciences|May 18, 2020
Modification of non-invasive ventilation for the advanced amyotrophic lateral sclerosis patient during the COVID-19 pandemic - do it nowEufrosina I Young, Dragos Manta, Birendra P Sah, et al.
Assistive Technology : the Official Journal of RESNA|December 23, 2015
Power Wheelchair Use in Persons With Amyotrophic Lateral Sclerosis: Changes Over TimeAmber Lea Ward, Sara Hammond, Scott Holsten, et al.
Journal of the Neurological Sciences|November 12, 2024
Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trialErik P Pioro, Benjamin Rix Brooks, Ying Liu, et al.
Plos One|August 31, 2013
PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditionsBenjamin Rix Brooks, David Crumpacker, Jonathan Fellus, et al.
The American Journal of Managed Care|April 26, 2018
Edaravone in the treatment of amyotrophic lateral sclerosis: efficacy and access to therapy - a roundtable discussionBenjamin Rix Brooks, James A Jorgenson, Barbara J Newhouse, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|October 26, 2021
Psychometric Properties of Rapid Word-Based Rate Measures in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Comparisons With Syllable-Based Rate TasksSanjana Shellikeri, Reeman Marzouqah, Benjamin Rix Brooks, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Toxicology and Applied Pharmacology|January 18, 2011
Methyl Vitamin B12 but not methylfolate rescues a motor neuron-like cell line from homocysteine-mediated cell deathRichelle A Hemendinger, Edward J Armstrong, Benjamin Rix Brooks
Trends in Molecular Medicine|April 1, 2009
Whole-genome association studies of sporadic amyotrophic lateral sclerosis: are retroelements involved?Jean-Luc Mougeot, Stephanie Richardson-Milazi, Benjamin Rix Brooks
Muscle & Nerve|February 7, 2026
Generalizability of Edaravone EfficacyBenjamin Rix Brooks, David L Ennist, Danielle Beaulieu, et al.
Toxicology and Applied Pharmacology|November 24, 2011
Neurotoxic injury pathways in differentiated mouse motor neuron-neuroblastoma hybrid (NSC-34D) cells in vitro--limited effect of riluzole on thapsigargin, but not staurosporine, hydrogen peroxide and homocysteine neurotoxicityRichelle A Hemendinger, Edward J Armstrong, Nick Radio, et al.
Journal of the Neurological Sciences|May 18, 2020
Modification of non-invasive ventilation for the advanced amyotrophic lateral sclerosis patient during the COVID-19 pandemic - do it nowEufrosina I Young, Dragos Manta, Birendra P Sah, et al.
Assistive Technology : the Official Journal of RESNA|December 23, 2015
Power Wheelchair Use in Persons With Amyotrophic Lateral Sclerosis: Changes Over TimeAmber Lea Ward, Sara Hammond, Scott Holsten, et al.
Journal of the Neurological Sciences|November 12, 2024
Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trialErik P Pioro, Benjamin Rix Brooks, Ying Liu, et al.
Plos One|August 31, 2013
PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditionsBenjamin Rix Brooks, David Crumpacker, Jonathan Fellus, et al.
The American Journal of Managed Care|April 26, 2018
Edaravone in the treatment of amyotrophic lateral sclerosis: efficacy and access to therapy - a roundtable discussionBenjamin Rix Brooks, James A Jorgenson, Barbara J Newhouse, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|October 26, 2021
Psychometric Properties of Rapid Word-Based Rate Measures in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Comparisons With Syllable-Based Rate TasksSanjana Shellikeri, Reeman Marzouqah, Benjamin Rix Brooks, et al.
Pageof 5